Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse

LEUKEMIA

NATURE PUBLISHING GROUP

1. University of Texas MD Anderson Cancer Center Support Grant [P30 CA16672]
2. Leukemia SPORE Grant [P50 CA100632]
3. NATIONAL CANCER INSTITUTE [P30CA016672, P50CA100632] Funding Source: NIH RePORTER